- Avid Bioservices, Inc. has opened a 78,000 square foot Early Phase Center of Excellence in Costa Mesa, California.
- The facility is designed to support early clinical biologics programs and provide integrated CDMO and contract manufacturing services from cell line development through commercial manufacturing.
Avid Bioservices, Inc., a biologics contract development and manufacturing organization (CDMO), has announced the grand opening of its new Early Phase Center of Excellence in Costa Mesa, California. The 78,000 square foot facility is purpose-built to support early clinical programs and expand the company’s development footprint in the United States.
The new center is designed to accelerate early-stage development timelines by integrating cell line development, upstream and downstream process and analytical development, IND-enabling analytical method qualification and testing, early formulation development, and tech transfer into Avid’s CGMP manufacturing facilities. The facility aligns with Avid’s commercial manufacturing operations to ensure consistency and support progression from preclinical development through commercial supply.
“Our new Early-Phase Center of Excellence is purpose-built to help both established pharma and innovative biotech companies move into the clinic faster – in a predictable way, with quality and stability as the foundation.”
Kenneth Bilenberg, Chief Executive Officer of Avid Bioservices
The Costa Mesa expansion increases Avid’s capacity to support a range of biologics, including monoclonal antibodies and recombinant proteins. The company stated that the center’s integrated workflows and technology platforms are designed to reduce development risk and support phase-appropriate development from early stages through full-scale CGMP contract manufacturing. The facility is now fully operational and accepting new programs.
